Skip to main content
OpenTrials
Completed

NCT Number: NCT00332514

Post-Discharge Follow-Up Phone Call by a Pharmacist and Impact on Patient Care

The purpose is to analyze whether a follow-up telephone call by a pharmacist after patient discharge from the hospital can improve patient outcomes.

Patients will be interviewed via telephone within 72 hours of being discharged home from the hospital. Patients will be questioned on three main topics. They are:

1. Medical care 2. Medications 3. Follow-up appointments

The purpose is to find out if people understand discharge medications, have obtained those medications, are having any problems with their medications and have scheduled necessary follow-up appointments. It will be determined if a telephone call by a pharmacist will prevent patients from needing to go to the Emergency Room or being admitted back to the hospital.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Boston Medical Center

Boston, Massachusetts, 02118, United States

About this study

There is a time between hospital discharge and patient follow-up that has been deemed by many healthcare workers as a "black hole " (1). It is a time during which continuity of care is of utmost importance, yet there is no effective uniform system in place to ensure this vital continuity. During the post-discharge period (time from when the patient leaves the hospital to the time of first follow-up appointment), new medical problems can arise and old ones can be exacerbated. Additionally, patients can encounter innumerable barriers to healthcare, including difficulty obtaining medications and securing appointments with physicians or specialists. Also, patients may not have received proper counseling on new discharge medications, including proper use and potential side effects. Despite this important aspect of patient care, only a paucity of literature on the topic exists. Of the literature that does exist, it suggests that patient education concerning discharge planning and the post-discharge period is an aspect of care that is in great need of improvement and an excellent opportunity for intervention by a pharmacist.

This led to our research hypothesis, can a follow-up phone call from a pharmacist improve patient outcomes?

The primary endpoint of this study is a reduction in the number of hospital readmissions (any cause) during the 30-day post-discharge period. Thirty-day readmission rates will be compared to see if there is a difference between the intervention group (follow-up phone call) and control group (no phone call). The secondary outcomes include the number of patients in the study group for whom medication errors, complications or misuse could be identified.

References: (1). Kathuria, et al. Post-discharge follow-up: hospitalists dial into the "black hole". Hospitalist and Inpatient Management Report, June 2003

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • admission to Internal Medicine Service on the Menino Pavilion, either Firm A or B at Boston Medical Center located in Boston, MA
  • age greater than or equal to 18 years
  • discharge to home from the inpatient General Medical Service
  • English-speaking or lives with English-speaking person
  • access to a working phone

Exclusion criteria

  • admission to any other service at Boston Medical Center located in Boston, MA besides Internal Medicine Firms A or B
  • age less than 18 years
  • discharge to site other than home
  • non-English-speaking or does not live with an English-speaking person
  • no access to a working phone

Treatment and study plan

telephone call by a pharmacist

Behavioral

Primary outcomes

  1. The primary endpoint of this study is a reduction in the number of hospital readmissions (any cause) during the 30-day post-discharge period.

Secondary outcomes

  1. The secondary outcomes include the number of patients in the study group for whom medication errors, complications or misuse could be identified.

Sponsors and collaborators

Lead sponsor

Boston Medical Center

Other

Registry information

Important dates

Study start
2004
Primary completion
2008
Study completion
2008
First posted
Jun 1, 2006
Registry last updated
Feb 23, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.